At EIDO Healthcare we are committed to helping our customers achieve excellence in the vital areas of informed consent and clinical governance. We provide medico-legally sound patient information and digital solutions to strengthen, optimise and continually improve shared decision-making for treatment and surgery.
With over 20 years’ experience, EIDO’s informed consent solutions are used in over 1,000 hospitals worldwide across five continents, by over eight million patients annually, within 65 per cent of acute NHS hospitals and 85 per cent of acute private hospitals
Our Inform Consent Suite provides a complete range of resources and consent solutions that meet the needs of healthcare professionals and systems providers.
Cloud-based, these solutions have been developed to support health professionals in taking and recording truly informed patient consent. Our focus is on enhancing clinician-patient engagement and experience, improving clinical workflows, protecting organisational and clinical reputations, and ultimately delivering better patient outcomes.
EIDO Healthcare provides patient-centred world class standardised educational material for surgical procedures while our digital solutions help improve patient education, understanding and engagement.
Our documents are extremely easy to read and understand and are made available in over 20 languages, many of which are also supported by high-quality animations that inform patients about their procedures without alarming them.
The EIDO Inform library of 400+ treatment-specific information articles, has been written and peer-reviewed by a carefully selected panel of 100+ specialty expert contributors. It can be purchased directly by hospitals, health authorities, or seamlessly integrated by third party healthcare technology providers into other systems.
The combined delivery of printable PDFs and digital solutions means EIDO is uniquely placed and experienced to support health boards at any/all points along their digital transformation journey.
Related posts
Interviews
Comment
We need to shout about our successes. Liz Fletcher on celebrating women in biotech
Throughout my career in biotechnology and life sciences, I have seen many women leading ground-breaking research studies in their fields of expertise. Yet, and I include myself in this, we…
Getting the best out of patient data is key to unlocking future health benefits in Scotland
It is important that clinicians’ voices are heard in the consultation around Scotland’s new health and care data strategy, which closes this week (12 August). Busy GPs like myself are the trusted…
How motherhood helped me be a better leader
Consider this an open letter to anyone I have worked with before I became a mother and before I fully understood how being a parent is actually a prized asset…
‘We cannot achieve our goals without entrepreneurs’ – Kate Forbes on vision for new ‘tech scaler’ network
From the very start of my ministerial career, I have had responsibility for the Scottish tech sector – and I can still say what I have said from the start,…
Finding a role in cyber was ‘tough’ for Cheryl Torano. Now she’s determined to help other women join an under-represented industry
When I decided to upskill to change careers at the age of 30 and dive into the digital world, I knew I would be starting out at the bottom of…
Why innovation and marketing are the perfect partners to make changes that matter
With the rapid evolution of traditional marketing and the appearance of digital marketing, technology and innovation has become part of any marketer’s life without the need of working for a…
Transitioning to a four-day week – CEO’s vow to strike a healthier balance in the workplace
I came to Scotland nearly 20 years ago from Ireland, with no contacts but a lot of determination. While Ireland will always be my home, Scotland has given me amazing…
Women Lead: The female-led company championing intuitive working
Over the last two years, the pandemic forced a shift to more remote and flexible working practices. Whilst we might be seeing a “return to normal”, some companies are choosing…